ACROBiosystems collaborates with ProMab Biotechnologies to develop immunotherapy products

ACROBiosystems, a leading manufacturer of recombinant proteins, announced that they have signed a collaboration agreement with ProMab Biotechnologies, a leading manufacturer of monoclonal antibodies and CAR-T cells.

The combination of ACROBiosystems protein portfolio, innovation lab capabilities and ProMab’s distinct experience in antibody and CAR-T cell generation, together our companies can bring added value and support to cancer immunotherapy development”.

Mike Chen, CEO of ACROBiosystems

These two biotech companies have been producing innovative products and custom services in the life Bio Pharmaceutical Industry for decades.

It is exciting to formalize a collaboration with a company whom we respect and whose innovative services complement our own so well”.

John Wu, CEO of ProMab Biotechnologies

It is expected that the services offered through this collaboration will become available in either company’s websites in the next few weeks.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    ACROBiosystems. (2019, June 24). ACROBiosystems collaborates with ProMab Biotechnologies to develop immunotherapy products. News-Medical. Retrieved on April 21, 2024 from https://www.news-medical.net/news/20190307/ACROBiosystems-collaborates-with-ProMab-Biotechnologies-to-develop-immunotherapy-products.aspx.

  • MLA

    ACROBiosystems. "ACROBiosystems collaborates with ProMab Biotechnologies to develop immunotherapy products". News-Medical. 21 April 2024. <https://www.news-medical.net/news/20190307/ACROBiosystems-collaborates-with-ProMab-Biotechnologies-to-develop-immunotherapy-products.aspx>.

  • Chicago

    ACROBiosystems. "ACROBiosystems collaborates with ProMab Biotechnologies to develop immunotherapy products". News-Medical. https://www.news-medical.net/news/20190307/ACROBiosystems-collaborates-with-ProMab-Biotechnologies-to-develop-immunotherapy-products.aspx. (accessed April 21, 2024).

  • Harvard

    ACROBiosystems. 2019. ACROBiosystems collaborates with ProMab Biotechnologies to develop immunotherapy products. News-Medical, viewed 21 April 2024, https://www.news-medical.net/news/20190307/ACROBiosystems-collaborates-with-ProMab-Biotechnologies-to-develop-immunotherapy-products.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
ACROBiosystems opens new Innovation laboratory in Delaware